News | EP Mapping and Imaging Systems | August 17, 2020

Northwestern Medicine One of First to Use Dielectric Imaging System to Guide Cardiac Ablation

System reduces radiation exposure, provides 3-D, high-definition images of heart in real time


August 17, 2020 — A Northwestern Medicine Bluhm Cardiovascular Institute physician was the first electrophyiologist in Illinois to use a new advanced imaging system during cryo-ablation for atrial fibrillation. 

The Philips’ Kodex-EPD system uses dielectric imaging to creates 3-D, high-definition images of a patient’s cardiac structures in real time. A completely new approach to imaging the heart, dielectric imaging offers many benefits in comparison to current approaches, for both cryo and radiofrequency ablation procedures. The technology provides real-time 3-D imaging, reducing the need for X-ray imaging and radiation exposure.

Bradley Knight, M.D., medical director of cardiac electrophysiology at Northwestern Memorial Hospital, was one of the first in the country to use the Phillips Kodex-EPD system. The system offered 3-D, high-definition images of a patient’s heart, during an atrial fibrillation (AFib) ablation procedure Aug. 5, 2020.

“I was impressed that this completely new three-dimensional mapping system, which acts much like a GPS system, can accurately and quickly re-create the anatomy of the cardiac chamber of interest and display the heart’s electrical activity using any electrode pairs placed in the heart,” Knight said.

In cryoablation, imaging is critical to help the physician guide the catheter. 

“As the population ages more Americans are being diagnosed with AFib,” said Knight, who is also the Chester C. and Deborah M. Cooley Distinguished Professor of Cardiology at Northwestern University Feinberg School of Medicine. “We are always looking for the safest, most advanced treatments for our heart rhythm patients and I was pleased to partner on this new technology.”

The Kodex-EDP system has both FDA 510(k) clearance and European CE mark.

Northwestern Medicine’s Bluhm Cardiovascular Institute is one of the top 10 national programs for cardiology and heart surgery, according to U.S. News and World Report, and ranked the top cardiovascular program in Illinois and the surrounding states for more than 10 consecutive years. 

More than 6 million Americans may have AFib, a heart rhythm disorder when the upper and lower chambers of the heart beat out of synch, either too slowly, too quickly or simply irregularly. Symptoms can include heart palpitations, extreme fatigue, chest pain or shortness of breath, though some with AFib experience no symptoms.

A major risk of AFib is stroke, and one in seven strokes is attributed to AFib.

For more information: news.nm.org/about-northwestern-medicine.html

 

Related Kodex-EPD Dielectric Imaging System Content:

4 Key Takeaways From the 2019 Heart Rhythm Society Meeting

Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment
 


Related Content

News | Atrial Fibrillation

April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period ...

Home April 18, 2024
Home
News | Atrial Fibrillation

March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 28, 2024
Home
News | Atrial Fibrillation

February 27, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home February 27, 2024
Home
News | Atrial Fibrillation

February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...

Home February 06, 2024
Home
News | Atrial Fibrillation

February 2, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home February 02, 2024
Home
News | Atrial Fibrillation

January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed ...

Home January 18, 2024
Home
News | Atrial Fibrillation

December 29, 2023 — Boston Scientific Corporation has initiated the AVANT GUARD clinical trial to evaluate the safety ...

Home December 29, 2023
Home
News | Atrial Fibrillation

December 26, 2023 — Pulse Biosciences, Inc., a company primarily focused on leveraging its novel and proprietary CellFX ...

Home December 26, 2023
Home
News | Atrial Fibrillation

December 22, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home December 22, 2023
Home
News | Atrial Fibrillation

December 14, 2023 — Medtronic plc, a global leader in healthcare technology, today announced that the United States Food ...

Home December 14, 2023
Home
Subscribe Now